quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:59·161d
SECFiling
N2OFF Inc. logo

SEC Form 10-Q filed by N2OFF Inc.

NITO· N2OFF Inc.
Industrials
Original source

Companies

  • NITO
    N2OFF Inc.
    Industrials

Related

  • SEC53d
    SEC Form PRE 14A filed by N2OFF Inc.
  • SEC56d
    N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
  • SEC58d
    N2OFF Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
  • PR58d
    N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
  • PR71d
    MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
  • INSIDER71d
    Chief Executive Officer Palach David was granted 100,000 units of Restricted Shares of Common Stock (SEC Form 4)
  • INSIDER71d
    Controller Zakai Shlomo was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
  • INSIDER71d
    Director Weiss Amitay was granted 116,286 units of Restricted Shares of Common Stock (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022